These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 16307164)
1. Additional benefits of RAS blockade in the treatment of black hypertensives using valsartan/hydrochlorothiazide combination. Cardiovasc J S Afr; 2005; 16(5):285. PubMed ID: 16307164 [No Abstract] [Full Text] [Related]
2. Amlodipine + valsartan + hydrochlorothiazide. A 3-drug fixed-dose combination for hypertension: too many drawbacks. Prescrire Int; 2011 Mar; 20(114):67. PubMed ID: 21648225 [No Abstract] [Full Text] [Related]
3. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306 [TBL] [Abstract][Full Text] [Related]
4. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study. Lacourcière Y; Wright JT; Samuel R; Zappe D; Purkayastha D; Black HR; Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192 [TBL] [Abstract][Full Text] [Related]
5. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension. Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820 [TBL] [Abstract][Full Text] [Related]
6. Effect of valsartan, hydrochlorothiazide, and their combination on 24-h ambulatory blood pressure response in elderly patients with systolic hypertension: a ValVET substudy. Duprez DA; Weintraub HS; Cushman WC; Purkayastha D; Zappe D; Samuel R; Izzo JL Blood Press Monit; 2011 Aug; 16(4):186-96. PubMed ID: 21747241 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of pharmacokinetic interactions between amlodipine, valsartan, and hydrochlorothiazide in patients with hypertension. Bhad P; Ayalasomayajula S; Karan R; Leon S; Riviere GJ; Sunkara G; Jarugula V J Clin Pharmacol; 2011 Jun; 51(6):933-42. PubMed ID: 20852001 [TBL] [Abstract][Full Text] [Related]
8. Amlodipine/valsartan/hydrochlorothiazide: fixed-dose combination in hypertension. Deeks ED Am J Cardiovasc Drugs; 2009; 9(6):411-8. PubMed ID: 19929039 [TBL] [Abstract][Full Text] [Related]
10. Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database. Jackson KC; Sheng X; Nelson RE; Keskinaslan A; Brixner DI Clin Ther; 2008 Aug; 30(8):1558-63. PubMed ID: 18803997 [TBL] [Abstract][Full Text] [Related]
11. Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers. Vaidyanathan S; Valencia J; Kemp C; Zhao C; Yeh CM; Bizot MN; Denouel J; Dieterich HA; Dole WP Int J Clin Pract; 2006 Nov; 60(11):1343-56. PubMed ID: 17073832 [TBL] [Abstract][Full Text] [Related]
12. Single-pill triple-combination therapy: an alternative to multiple-drug treatment of hypertension. Chrysant SG Postgrad Med; 2011 Nov; 123(6):21-31. PubMed ID: 22104451 [TBL] [Abstract][Full Text] [Related]
13. Valsartan/hydrochlorothiazide: a review of its use in the management of hypertension. Wagstaff AJ Drugs; 2006; 66(14):1881-901. PubMed ID: 17040120 [TBL] [Abstract][Full Text] [Related]
14. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension. Frampton JE; Scott LJ Am J Cardiovasc Drugs; 2009; 9(5):309-30. PubMed ID: 19791840 [TBL] [Abstract][Full Text] [Related]
15. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial. Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480 [TBL] [Abstract][Full Text] [Related]
16. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing. Hermida RC; Ayala DE; Mojón A; Fontao MJ; Fernández JR Chronobiol Int; 2011 Aug; 28(7):601-10. PubMed ID: 21823969 [TBL] [Abstract][Full Text] [Related]
17. Time to achieve blood-pressure goal: influence of dose of valsartan monotherapy and valsartan and hydrochlorothiazide combination therapy. Weir MR; Levy D; Crikelair N; Rocha R; Meng X; Glazer R Am J Hypertens; 2007 Jul; 20(7):807-15. PubMed ID: 17586417 [TBL] [Abstract][Full Text] [Related]
18. Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safety. Calhoun DA; Crikelair NA; Yen J; Glazer RD Adv Ther; 2009 Nov; 26(11):1012-23. PubMed ID: 20024680 [TBL] [Abstract][Full Text] [Related]
19. Telmisartan or valsartan alone or in combination with hydrochlorothiazide: a review. Lacourcière Y Clin Exp Hypertens; 2013; 35(1):50-60. PubMed ID: 22866964 [TBL] [Abstract][Full Text] [Related]
20. Distinct effects of fixed combinations of valsartan with either amlodipine or hydrochlorothiazide on lipoprotein subfraction profile in patients with hypertension. Christogiannis LG; Kostapanos MS; Tellis CC; Milionis HJ; Tselepis AD; Elisaf MS J Hum Hypertens; 2013 Jan; 27(1):44-50. PubMed ID: 22129607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]